Evaluation of the results of treatment of morbid obesity by the endoscopic intragastric balloon implantation method

Wojciech Żurawiński, Dariusz Sokołowski, Karolina Krupa-Kotara, Elżbieta Czech, Krystyn Sosada, Wojciech Żurawiński, Dariusz Sokołowski, Karolina Krupa-Kotara, Elżbieta Czech, Krystyn Sosada

Abstract

Introduction: Overweight and obesity are ranked in the fifth place among the risk factors responsible for the greatest number of deaths in the world.

Aim: To assess the effects of treatment of patients with morbid obesity using endoscopic intragastric balloon (IGB) implantation.

Material and methods: Two hundred and seventy-two patients with obesity were treated using endoscopic intragastric balloon implantation. Upon analysis of the inclusion and exclusion criteria, the study covered a group of 63 patients with morbid obesity. The patients were implanted with the LexBal balloon. Reduction of excess body mass, changes to BMI values and ailments and complications divided into mild and severe were assessed.

Results: Before intragastric balloon treatment, the average body mass index (BMI) value was 58.3 ±10.5 kg/m2, whereas after 6 months of treatment it decreased to 49.5 ±8.7 kg/m2. The patients with postoperative BMI equal to or greater than 50.0 kg/m2 reported nausea (69.7%), vomiting (51.5%), flatulence (45.5%), upper abdominal pain (36.4%) and general discomfort (424%) more frequently. Dehydration (9.1%) was also more frequent in this group, whereas frequency of occurrence of such ailments and complications as heartburn (23.3%) and oesophageal candidiasis (10.0%) was higher in the patients with postoperative BMI below 50.0 kg/m2.

Conclusions: Endoscopic intragastric balloon implantation is an effective and safe method of excess body mass reduction in patients with morbid obesity before a planned bariatric surgical procedure. Pre-operative excess body mass and BMI value and post-operative excess weight loss in patients with morbid obesity have no impact on frequency of occurrence of ailments and complications in IGB treatment.

Keywords: endoscopy; intragastric balloon; morbid obesity.

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Photo 1
Photo 1
Balloon during inflation with physiological saline upon deployment into the stomach
Photo 2
Photo 2
Balloon upon complete filling up to 700 ml volume – controlling the balloon placement and valve tightness
Photo 3
Photo 3
Intragastric balloon upon suctioning its content
Figure 1
Figure 1
Average body mass of the patients with morbid obesity before and after 6 months of treatment with an intragastric balloon depending on sex

References

    1. World Health Organization. Obesity and overweight. Fact Sheets No. 311. 2006. [accessed on: 13.12.2016 ]
    1. Deitel M. Overweight and obesity worldwide now estimated to involve 1.7 billion people. Obes Surg. 2003;13:329–30.
    1. Central Statistical Office. Health condition of population in Poland in 2009. Warsaw: Zakład Wydawnictw Statystycznych; 2011.
    1. Stanowski E, Wyleżoł M, Paśnik K. Laparoskopia w chirurgii bariatrycznej w Polsce – stan aktualny. [Laparoscopy in bariatric surgery in Poland – current condition]. Videosurgery Miniinv. 2008;3:18–23.
    1. Zejda JE, Zahorska-Markiewicz B. Epidemiologia nadwagi i otyłości w populacji aglomeracji katowickiej. [Epidemiology of excess weight and obesity in population of Katowice agglomeration]. Med Metabol. 2004;8:22.
    1. World Health Organization. Department of Nutrition for Health and Development (NHD) Geneva: The WHO Global Database on BMI; 2006. [accessed on: 13.12.2016 website: ]
    1. Rasera I, Jr, Luque A, Junqueira SM, Jr, et al. Effectiveness and safety of bariatric surgery in the Public Healthcare System in Brazil: real-world evidence from a high-volume obesity surgery center. Obes Surg. 2017;27:536–40.
    1. Whitlock G, Lewington S, Sherliker P, et al. Body-mass index and cause-specific mortality in 900 000 adults: collaborative analyses of 57 prospective studies. Lancet. 2009;373:1083–96.
    1. Janik MR, Stanowski E, Paśnik K. Present status of bariatric surgery in Poland. Videosurgery Miniinv. 2016;11:22–5.
    1. Żurawiński W, Sosada K, Jopek J, Piecuch, et al. Endoscopic treatment of obesity with an intragastric balloon. Pol J Surg. 2010;82:754–61.
    1. De Waele B, Reynaert H, Urbain D, Willerns G. Intragastric balloons for preoperative weight reduction. Obes Surg. 2000;10:58–60.
    1. Loffredo A, Cappuccio M, De Luca M, et al. Three years experience with the new intragastric balloon, and a preoperative test for success with restrictive surgery. Obes Surg. 2001;11:330–3.
    1. Doldi SB, Micheletto G, Di Prisco F. Intragastric balloons in obese patients. Obes Surg. 2000;10:578–81.
    1. Fred M, Hainer W, Basdevant A, et al. Interdisciplinary European guidelines on surgery of severe obesity. Endokrynol Otyłość. 2009;5:99–108.
    1. Nieben OG, Harboe H. Intragastric balloon as an artificial bezoar for treatment of obesity. Lancet. 1982;1:198–9.
    1. Kirby DF, Wade JB, Mills PR, et al. A prospective assessment of the Garren-Edwards gastric bubble and bariatric surgery in the treatment of morbid obesity. Am Surg. 1990;56:575–80.
    1. Meshkinpour H, Hsu D, Farivar S. Effect of gastric bubble as a weight reduction device: a controlled, crossover study. Gastroenterology. 1988;95:589–92.
    1. Schapiro M, Benjamin S, Blackburn G, et al. Obesity and the gastric balloon: a comprehensive workshop. Tarpon Springs, Florida, March 19-21, 1987. Gastrointest Endosc. 1987;33:323–7.
    1. Gau MD. Clinical trial protocol SIB-001 silicone intragastric balloon: Final Report. 1989. Mar, INAMED.
    1. Sallet JA, Marchesini JB, Paiva DS, et al. Brazilian multicenter study of the intragastric balloon. Obes Surg. 2004;14:991–8.
    1. Mion F, Napoléon B, Roman S, et al. Effects of intragastric balloon on gastric emptying and plasma ghrelin levels in non-morbid obese patients. Obes Surg. 2005;15:510–6.
    1. Göttig S, Daskalakis M, Weiner S, Weiner RA. Analysis of safety and efficacy of intragastric balloon in extremely obese patients. Obes Surg. 2009;19:677–83.
    1. Genco A, Bruni T, Doldi B, et al. BioEnterics Intragastric Balloon: the Italian experience with 2515 patients. Obes Surg. 2005;15:1161–4.
    1. Mathus-Vliegen EM, Tytgat GN. Intragastric balloon for treatment-resistant obesity: safety, tolerance, and efficacy of 1-year balloon treatment followed by a 1-year balloon-free follow-up. Gastrointest Endosc. 2005;61:19–27.
    1. Al Kahtani K, Qaseem Khan M, Helmy A, et al. Bio-enteric intragastric balloon in obese patients: a retrospective analysis of King Faisal Specialist Hospital experience. Obes Surg. 2010;20:1219–26.
    1. Pawlik M, Rydzewska G. Metody terapeutyczne leczenia otyłości z uwzględnieniem zastosowania balonów dożołądkowych. [Therapeutic methods of obesity treatment with consideration to application of intragastric balloons]. Pol Merk Lek. 2009;16:527–31.
    1. Mitura K, Garnysz K. Tolerance of intragastric balloon and patient’s satisfaction in obesity treatment. Videosurgery Miniinv. 2015;10:445–9.
    1. Van Hout G. Psychosocial effects of bariatric surgery. Acta Chir Belg. 2005;105:40–3.
    1. Evans JD, Scott MH. Intragastric balloon in the treatment of patients with morbid obesity. Br J Surg. 2001;88:1245–8.
    1. Pretolesi F, Redaelli G, Papagni L, et al. Intragastric balloon for morbid obesity causing chronic gastric dilatation. Eur Radiol. 2001;11:588–9.
    1. Nijhof HW, Steenvoorde P, Tollenaar RA. Perforation of the oesophagus caused by the insertion of an intragastric balloon for the treatment of obesity. Obes Surg. 2006;16:667–70.
    1. Giardiello C, Cristiano S, Cerbone MR, et al. Gastric perforation in an obese patient with an intragastric balloon, following previous fundoplication. Obes Surg. 2003;13:658–60.
    1. Kim WY, Kirkpatrick UJ, Moody AP, et al. Large bowel impaction by the Bioenterics intragastric balloon necessitating surgical intervention. Ann R Coll Surg Engl. 2000;82:202–4.
    1. Mathus-Vliegen EM, Tygat GN. Gastrooesophageal reflux in obese subjects: influence of overweight, weight loss and chronic gastric balloon distension. Scand J Gastroenterol. 2002;37:1246–52.
    1. Zheng Y, Wang M, He S, Ji G. Short-term effects of intragastric balloon in association with conservative therapy on weight loss: a meta-analysis. J Transl Med. 2015;29:246.

Source: PubMed

赞助者和合作者

医疗条件

药物干预

3
订阅